Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A novel Iowa-Mayo validated composite risk assessment tool for allogeneic stem cell transplantation survival outcome prediction.
Blood Cancer J. 2021 Nov 20;11(11):183. doi: 10.1038/s41408-021-00573-6.
Blood Cancer J. 2021.
PMID: 34802042
Free PMC article.
Clinical Trial.
VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma.
Nadiminti K, Singh Abbi KK, Mott SL, Dozeman L, Tricot A, Schultz A, Behrends S, Zhan F, Tricot G.
Nadiminti K, et al. Among authors: dozeman l.
Onco Targets Ther. 2017 Jan 6;10:217-226. doi: 10.2147/OTT.S112423. eCollection 2017.
Onco Targets Ther. 2017.
PMID: 28123303
Free PMC article.
Item in Clipboard
Potential pitfalls of serum free light chain analysis to assess treatment response for multiple myeloma.
Abbi KK, Silverman M, Farooq U, Tricot A, Dozeman L, Nadiminti K, Krasowski MD, Tricot GJ.
Abbi KK, et al. Among authors: dozeman l.
Br J Haematol. 2016 Aug;174(4):536-40. doi: 10.1111/bjh.14081. Epub 2016 May 12.
Br J Haematol. 2016.
PMID: 27172326
Free article.
Item in Clipboard
Cite
Cite